NCT06305169View on ClinicalTrials.gov

Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

440

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

July 1, 2024

Conditions
Gastric Cancer
Interventions
DIAGNOSTIC_TEST

Gastropanel

Gastropanel is a commercially available blood test which given serum levels of pepsinogen I and II and gastrin 17 along with helicobacter pylori infection status

Trial Locations (1)

B71 4HJ

Sandwell General Hospital, Birmingham

All Listed Sponsors
lead

Sandwell & West Birmingham Hospitals NHS Trust

OTHER

NCT06305169 - Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer | Biotech Hunter | Biotech Hunter